Despite medical breakthroughs and nationwide programs, Tuberculosis is making an unsettling return. Patients get cured, and then months later, relapse. Why is this recurrent? Is it the system or something deeper? Let’s break it down.
Cracks in the DOTS Shield
Directly Observed Treatment, Short-course (DOTS) was designed to change the game. But for many, it has become a double-edged sword.
DOTS is meant to ensure patients complete their medication under observation. In theory, it’s perfect. In reality:
● Patients drop out mid-treatment.
● Medications aren’t always available.
● Follow-ups fall through.
● Side effects are poorly managed.
This results in incomplete treatment, which is one of the top triggers for TB relapse.
When Protocols Ignore People
Every TB case is different—but the DOTS model is not.
Uniform Plans for Unpredictable Lives
Patients deal with more than TB. They live with job insecurity, stigma, and emotional stress. But DOTS doesn’t adjust.
● A laborer can’t visit a clinic daily without losing wages.
● A rural woman may hide her illness to avoid shame.
● Someone battling addiction or depression may simply stop taking pills.
The program doesn’t account for these human realities. The result? Gaps. Drop-offs. Relapses.
A Hidden Pattern in the Relapse Cycle
Relapses are not random. They often follow a rhythm—and a silence.
What Can Cause a Relapse?
● Early discharge: Patients are discharged when the symptoms are controlled, and not
when there is clearance of the bacteria.
● Drug resistance: When medication is stopped midway, TB comes back stronger.
● Missed reviews: No regular check-ins after treatment completion.
The worst part? Many relapsed cases go unreported. They’re not captured in official data,
which makes the problem invisible.
Rebuilding the Response: Where to Start
Fixing the relapse issue doesn’t need big talk—it needs sharp action.
What Can Be Done?
● Flexible treatment delivery: Community health workers must bring care to the patient.
● Better education: People need to know why the full course matters.
● Stronger follow-up systems: Track patients even after they’re declared “cured.”
● Psychosocial support: Care about an individual and not only about their ailment.
Instead one should ask whether they took their pills or not. it is a yes or no question, to which if
it is yes, it is: "Are they really recovering?"
Conclusion: The Missed Link
TB relapse is not just a medical failure—it’s a systems failure. One that’s quietly growing under
the illusion of success. DOTS, though well-intended, has cracks that allow old wounds to reopen.
Relapse doesn’t mean patients failed. It often means the system did.